Seoul, South Korea

Jiyoung Min

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jiyoung Min: Innovator in Mechanical Thrombectomy Devices

Introduction

Jiyoung Min is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of medical devices, particularly in the development of thrombectomy technologies. With a total of 2 patents, her work focuses on innovative solutions for treating vascular blockages.

Latest Patents

One of Jiyoung Min's latest patents is a mechanical thrombectomy device and method. This device includes several clot arrestors that are independently mounted on a support wire. The clot arrestors feature expandable frames that are eccentrically supported on the support wire. This design allows a clot to pass into and be captured by one of the expandable frames. Additionally, the independently and eccentrically mounted clot arrestors can deform independently of one another. This feature enables the mechanical thrombectomy device to navigate through tortuous vasculature, allowing one clot arrestor to stretch without affecting another. This innovative approach enhances the device's ability to retain clots effectively.

Career Highlights

Jiyoung Min is currently associated with Nventric Corporation, where she continues to advance her research and development efforts in medical technology. Her work has garnered attention for its potential to improve patient outcomes in vascular treatments.

Collaborations

Jiyoung collaborates with talented individuals such as Don Quy Ngo and Sungwoo Min, contributing to a dynamic team focused on innovation in medical devices.

Conclusion

Jiyoung Min's contributions to the field of thrombectomy devices exemplify her commitment to advancing medical technology. Her innovative designs and collaborative efforts position her as a key figure in the ongoing development of effective vascular treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…